Search filters

List of works by Tammy M Havener

A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT.

scientific article published on November 2012

Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics.

scientific article

Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial

scientific article published in 2017

Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis

scientific article published in May 2004

Genetic Variants in CPA6 and PRPF31 are Associated with Variation in Response to Metformin in Individuals with Type 2 Diabetes.

scientific article published on 12 April 2018

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

scientific article published on 24 July 2017

Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines

scientific article

Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response

scientific article published on 17 August 2016

Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care

scientific article

Synergistic drug combinations and machine learning for drug repurposing in chordoma

scientific article published on 31 July 2020

The influence of Neanderthal alleles on cytotoxic response

scientific article published on 23 October 2018